King Pharmaceuticals KG Number of independent directors
Number of independent directors at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept kg:NumberOfIndependentDirectors.
The source filing: King Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 8:49 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054606
Following completion of the Combination, the board of directors of Kestrel Group consists of seven directors, made up of four directors selected by Kestrel Intermediate Ledbetter Holdings LLC, two of whom are independent under applicable securities laws and stock exchange rules, and three directors selected by AmTrust Financial Services, Inc. (“AmTrust”), two of whom are independent under applicable securities laws and stock exchange rules. Please see Note 10. Related Party Transactions for information regarding the Company's relationship with AmTrust.
Item 1. Financial Statements
FAQ
- What is King Pharmaceuticals's number of independent directors?
- King Pharmaceuticals (KG) reported number of independent directors of $2 in Q2 2025.
- What does number of independent directors mean?
- Number of independent directors as reported by Kestrel Group Ltd.
Ask your AI about King Pharmaceuticals's number of independent directors.
Connect your AI assistant and compare it to peers, right in your chat.
